Advaxis' PIPE - II Round

Advaxis raised a round of funding on September 22, 2009.

Advaxis, Inc. is a biotechnology company that uses a bioengineered bacterium, Listeria monocytogenes to activate the immune system to treat cancer, infectious disease or allergic syndromes.…

Articles about Advaxis' PIPE - II Round: